News Releases
February/March webinar series highlights key 2025 changes to payment and coverage policies that impact wound care, providing actionable insights to help health professionals navigate complex policies and ensure they are prepared for changes that affect clinical practice.
(February 4, 2025) — An educational partnership between HMP Global and the Alliance of Wound Care Stakeholders will give health care professionals the critical information they need to understand the impact of 2025 Medicare policy updates on wound care. The new webinar series will address key changes to payment and coverage policies and their impacts, ensuring that wound care providers are equipped with the knowledge needed to implement these changes effectively in their practices. The seminar series in February and March will specifically focus on new provisions within the 2025 Medicare Physician Fee Schedule (MPFS), the Hospital Outpatient Prospective Payment System (OPPS), and the Home Health Prospective Payment System (HH PPS), plus the Local Coverage Determinations (LCDs) on Cellular and Tissue-Based Products (CTPs/skin substitutes) for Diabetic Foot Ulcers and Venous Leg Ulcers and their accompanying Billing and Coding Articles.
Each of the three webinars will summarize the “need to know” 2025 policy updates, then delve into how changes will impact clinicians across different care settings, including private practices, provider-based departments, and home health services. Experts will share real-world implementation experiences, challenges and tips.
- Ready! Set! Go! Implement 2025 Medicare Final Rules: MPFS, OPPS, and Home Health PPS
Wednesday, February 12 at 1 p.m. ET
Speakers: Karen S. Ravitz, JD, Health Policy Advisor, Alliance of Wound Care Stakeholders; Kathleen D. Schaum, MS, President, Kathleen D. Schaum & Associates
REGISTER TODAY
- Tips for Implementing the CTP LCD in Your Practice
Wednesday, February 26 at 2 p.m. ET
Speakers: Kathleen D. Schaum, MS; Kara Couch, MS, CRNP, Director of Wound Care Services, George Washington University Hospital; Gayle M. Gordillo, MD, FACS, Senior Medical Director of Wound Services, University of Pittsburgh Medical Center; Marcia Nusgart, R.Ph., CEO and Founder of the Alliance of Wound Care Stakeholders; Karen S. Ravitz, JD
(Registration Opens Soon)
1/25/25 - All of the Medicare Administrative Contractors (MACs) have delayed the effective date of the final local coverage determinations for cellular and tissue-based products for wounds (CTPs, or "skin substitutes") in diabetic foot ulcers and venous leg ulcers by 60 days, moving the implementation date across all MAC jurisdictions from 2/12/25 to 4/13/25.
Note: the local coverage determinations themselves are unchanged, only the effective date has postponed.
As there were seismic changes to the number of covered products, allowable applications, and required documentation in the final LCDs published in November 2024, wound care providers across the country who treat DFU/VLU in Medicare beneficiaries have been preparing for the original February 12, 2025 implementation date. This 60 day postponement to April 13th has the upside of providing additional preparation time.See the "Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers & Venous Leg Ulcers" LCDs from each MAC below.
Statement from the Alliance of Wound Care Stakeholders
November 19, 2024 – The Alliance of Wound Care Stakeholders is pleased that CMS’ Medicare Administrative Contractors (MACs) carefully considered stakeholder recommendations and made substantive changes following input from the wound care community in the recently released final Local Coverage Determinations (LCDs) and accompanying Coding and Billing Articles, “Skin Substitute Grafts/Cellular and Tissue-Based Products (CTPs) for the Treatment of Diabetic Foot Ulcers & Venous Leg Ulcers.” With publication of the final policy by each MAC, the wound care community now has clearer understanding of Medicare coverage for the application of CTP/skin substitute products in treating diabetic foot ulcers (DFU) and venous leg ulcers (VLU). The Alliance and the larger wound care clinical community mobilized together, illustrating the power of tenacious advocacy and a unified voice to positively influence policies so that they reflect quality wound care practice. In a noted change that was in direct alignment with Alliance recommendations, the MACs increased the covered application limit from 4 to 8 in the final policy, now consistent with the supportive clinical evidence, treatment guidelines and current standard of care to promote wound healing. Similarly,
SEE NEWS RELEASE
SEE NEWS RELEASE
Read Alliance News Release
Read Alliance News Release
Read Alliance News Release
See Alliance News Release